• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed within each year since 1998, when FDA received its first GRAS notice. Once FDA has responded to a GRAS notice, the text of FDA's response will also be available as part of the record for that notice. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Search within these results
Records Found: 528 Show All Page 1 of 11
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter
528 Preparation containing six bacterial monophages (LIST-36, LMSP-25, LMTA-34, LMTA-57, LMTA-94 and LMTA-148) specific to Listeria monocytogenes Pending
527 Algal oil (87% oleic acid) derived from Prototheca moriformis strain S2532 Pending
526 Bacillus coagulans strain Unique IS2 spores preparation Pending
525 Pea fiber Pending
524 Phospholipase A2 enzyme preparation from Trichoderma reesei carrying a phospholipase A2 gene from Aspergillus nishimurae Pending
523 l-leucine Pending
522 Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract Pending
521 Congugated linoleic acid isomers Pending
520 Hydrogen gas Pending
519 Chlorella protothecoides strain S106 flour with 40-75% protein Pending
518 Galacto-oligosaccharides Pending
517 Natamycin Pending
516 Steviol glycosides with rebaudioside A and stevioside as the principal components Pending
515 D-beta-hydroxybutyrate ester Pending
514 Sucrose fatty acid esters Pending
513 Dried biomass of Euglena gracilis containing beta-1,3-glucan from Euglena gracilis Jul 10, 2014 At the notifier's request, FDA ceased to evaluate the notice
512 High purity Rebaudioside M Pending
511 Citric acid esters of mono- and diglycerides Pending
510 Acid lactase from Aspergillus oryzae expressed in Aspergillus niger Pending
509 Glucose oxidase enzyme preparation derived from Penicillium chrysogenum Pending
508 Salts from dried mineral water (65% NaCl) Pending
507 Amylomaltase enzyme preparation from Bacillus amyloliquefaciens carrying an amylomaltase gene from Thermus thermophiles Pending
506 Sacha inchi oil, a vegetable oil derived from Plukenetia volubilis. Pending
505 Phosphodiesterase I enzyme preparation from Leptographium procerum Pending
504 Concentrated milk proteins Pending
503 Tamarind seed polysaccharide Pending
502 Lactobacillus acidophilus La-14 Pending
501 L-theanine (chemically synthesized) Jul 30, 2014 FDA has no questions
500 Hydroethanolic extract of Caralluma fimbriata Pending
499 Magnesium L-threonate hydrate Pending
498 Psicose Jun 6, 2014 FDA has no questions
497 Polyphenols from the fruit of Litchi chinensis Sonn. and from leaves of Camellia sinensis (L.) Sinensis Jun 3, 2014 FDA has no questions
496 Aqueous extract of Brassica oleracea var. italica Plenck seeds. Pending
495 Galacto-oligosaccharides May 30, 2014 FDA has no questions
494 Fatty acid ethyl ester from anchovy or menhaden oil, standardized to approximately 50 percent palmitoleic acid Pending
493 High purity steviol glycosides (minimum purity 95%) May 30, 2014 FDA has no questions
492 Phytosterols and phytosterol esters Jun 24, 2014 FDA has no questions
491 Rooster combs extract Jun 6, 2014 FDA has no questions
490 Phospholipase A2 enzyme preparation from Trichoderma reesei Pending
489 Galacto-oligosaccharides May 22, 2014 FDA has no questions
488 Benzalkonium chloride Jun 12, 2014 At the notifier's request, FDA ceased to evaluate the notice
487 Dried citrus pulp Jun 5, 2014 FDA has no questions
486 Oil from the seeds of Buglossoides arvensis Pending
485 Beta-galactosidase enzyme preparation Apr 15, 2014 FDA has no questions
484 Galacto-oligosaccharides May 8, 2014 FDA has no questions
483 Aqueous extract of Emblica officinalis Mar 17, 2014 FDA has no questions
482 Beta-glucanase and xylanase enzyme preparation from Disporotrichum dimorphosporum Pending
481 Meso-zeaxanthin Apr 11, 2014 FDA has no questions
480 Dried aqueous extract derived from white kidney bean (Phaseolus vulgaris) May 30, 2014 FDA has no questions
479 Beta-glucanase, cellulase, and xylanase enzyme preparation from Talaromyces emersonii Mar 7, 2014 FDA has no questions

Show All 

jump to page of 11 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter
-
-